VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NNOX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NNOXNano-X Imaging Ltd.
$1.24$86M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NNOX logoNano-X Imaging Ltd.(NNOX)Earnings, Financials & Key Ratios

NNOX•NASDAQ
$1.24
Price updated Jul 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryImaging, radiation, and oncology devices
AboutNano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.Show more
  • Revenue$13M+15.4%
  • EBITDA-$49M-8.9%
  • Net Income-$75M-40.2%
  • EPS (Diluted)-1.16-27.5%
  • Gross Margin-98.21%-4.5%
  • EBITDA Margin-376.33%+5.7%
  • Operating Margin-466.16%+7.3%
  • Net Margin-576.13%-21.5%
  • ROE-45.62%-64.0%

NNOX Price & Volume

Nano-X Imaging Ltd. (NNOX) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operating Losses Challenge Commercialization Scaling Efforts

Investment Thesis • Updated 2025Q4

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Capital exhaustion and liquidity

Key Thesis Takeaways

  • Nano-X Imaging faces a precarious financial outlook as its transition to a hardware-as-a-service model struggles to overcome significant structural cost burdens.
  • While the company achieved a 24.0% year-over-year revenue increase in 2025Q4, the persistent negative gross margins of -97.3% and substantial quarterly net losses of $33.4 million raise existential concerns regarding its current business model.
  • Investors should monitor the company's ability to manage its $49.2 million cash position against ongoing operational burn, as the lack of a clear path to profitability may necessitate further dilutive financing.

Verdict Logic

the company's inability to generate positive gross margins, which stood at -97.3% in 2025Q4, combined with a consistent quarterly free cash flow deficit of $12.5 million, suggests a high risk of capital exhaustion.

NNOX Growth Metrics

Nano-X Imaging Ltd. (NNOX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years14.93%
TTM25.74%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-39.49%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-26.67%

Return on Capital

10 Years-32.62%
5 Years-31.28%
3 Years-30.99%
Last Year-35.57%

NNOX Recent Earnings

Nano-X Imaging Ltd. (NNOX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (27%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
Apr 20, 2026
Metric
Actual
Est
EPS
$0.50-117.4%
$0.23
Rev
$4M-12.5%
$4M
Q4 2025
Nov 20, 2025
Metric
Actual
Est
EPS
$0.65-333.3%
$0.15
Rev
$3M-13.7%
$4M
Q3 2025
Aug 12, 2025
Metric
Actual
Est
EPS
$0.23-31.4%
$0.17
Rev
$3M-13.3%
$4M
Q2 2025
May 22, 2025
Metric
Actual
Est
EPS
$0.21-10.5%
$0.19
Rev
$3M-17.2%
$3M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 20, 2026
$0.50vs $0.23-117.4%
$4Mvs $4M-12.5%
Q4 2025Nov 20, 2025
$0.65vs $0.15-333.3%
$3Mvs $4M-13.7%
Q3 2025Aug 12, 2025
$0.23vs $0.17-31.4%
$3Mvs $4M-13.3%
Q2 2025May 22, 2025
$0.21vs $0.19-10.5%
$3Mvs $3M-17.2%
Based on last 12 quarters of dataView full earnings history →

Latest NNOX News

Recent stock market news and headlines for Nano-X Imaging Ltd. (NNOX)

PRNewsWire·Jun 29, 2026
Nano-X Imaging Ltd. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NNOX

LOS ANGELES, June 29, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Nano-X Imaging Ltd. ("Nano-X" or "the Company") (NASDAQ: NNOX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Peers Comparison

Key metrics vs top competitors for Nano-X Imaging Ltd. (NNOX)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NNOX logoNNOXNano-X Imaging Ltd.Current
$1.24$86.3M-1.0715.4%-576.13%-45.62%—
HOLO logoHOLOMicroCloud Hologram Inc.
$1.53$20.16M-2.6535.27%-13.06%-1.89%—
ATEC logoATECAlphatec Holdings, Inc.
$9.38$1.42B-9.7724.95%-21.07%-443.09%—
PRCT logoPRCTPROCEPT BioRobotics Corporation
$21.03$1.2B-12.2337.22%-31.82%-27.7%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$64.89$29.52B14.264.84%7.54%14.45%—
SYK logoSYKStryker Corporation
$313.38$120.14B37.3111.16%13.21%15.1%—

Compare NNOX vs Peers

Nano-X Imaging Ltd. (NNOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HOLO

Most directly comparable listed peer for NNOX.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare NNOX against a more recognizable public peer.

Peer Set

Compare Top 5

vs HOLO, ATEC, PRCT, GEHC

Get notified when NNOX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NNOX Frequently Asked Questions

Nano-X Imaging Ltd. (NNOX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Nano-X Imaging Ltd.'s revenue?

Nano-X Imaging Ltd. (NNOX) reported $14.5M in revenue for fiscal year 2025.

How fast is Nano-X Imaging Ltd. growing?

Nano-X Imaging Ltd. (NNOX) grew revenue by 15.4% over the past year. This is strong growth.

Is NNOX profitable?

Nano-X Imaging Ltd. (NNOX) reported a net loss of $76.0M for fiscal year 2025.

Dividend & Returns
What is NNOX's return on equity?

Nano-X Imaging Ltd. (NNOX) has a return on equity (ROE) of -45.6%. Negative ROE indicates the company is unprofitable.

What is Nano-X Imaging Ltd.'s free cash flow?

Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $51.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in NNOX back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →